Arrhythmogenic right ventricular cardiomyopathy/dysplasia (<scp>ARVC</scp>/D) in clinical practice
Ka Hou Christien Li(Newcastle University), Gary Tse(Observational & Pragmatic Research Institute), William Ka Kei Wu(Quantitative BioSciences), George Bazoukis(Evangelismos Hospital), Martin C. S. Wong(Chinese University of Hong Kong), Vassilios S. Vassiliou(Bank of Cyprus Oncology Center), Tong Liu(Second Hospital of Tianjin Medical University), Guangping Li(Qingdao University), Yat Sun Chan(Chinese University of Hong Kong), Katharina Wassilew(Copenhagen University Hospital), Wing Tak Wong(Chinese University of Hong Kong), Sunny H. Wong(Nanyang Technological University)
Cited by 35
Related Papers
Risk Factors Associated With Post−COVID-19 Condition
|JAMA Internal Medicine|2023|784
Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong
|Vaccine|2021|605
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
|Journal of the American College of Cardiology|2019|494
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
|Nature Medicine|2016|393